Onjuist geneesmiddelgebruik bij ouderen opsporen.: De herziene STOPP- en START-criteria

Wilma Knol; Monique M Verduijn; A C A M Rian Lelie-van der Zande; Rob J van Marum; Jacobus Brouwers; Tischa J M van der Cammen; Mirko Petrovic; Paul A F Jansen

Onjuist geneesmiddelgebruik bij ouderen opsporen. De herziene STOPP- en START-criteria

Translated title of the contribution: Detecting inappropriate medication in older people: the revised STOPP/START criteria

Wilma Knol, Monique M Verduijn, A C A M Rian Lelie-van der Zande, Rob J van Marum, Jacobus Brouwers, Tischa J M van der Cammen, Mirko Petrovic, Paul A F Jansen

Research output: Contribution to journal › Article › Academic › peer-review

17 Citations (Scopus)

Abstract

The use of potentially inappropriate medications (PIMs) by older people and potential prescribing omissions (PPOs) represent a serious problem. It increases the risk of adverse drug reactions (ADRs), however it is susceptible to influence in a substantial number of cases. Use of the STOPP/START criteria developed in Ireland to optimise pharmacotherapy of older people reduces the number of ADRs and medication errors. Licensing of new drugs, the increased number of potentially inappropriate drugs, and the availability of new literature were grounds for an update of the first version of the STOPP/START criteria which was published in 2008. In order to develop a screening tool with a broader application, a consensus panel of experts in the field of pharmacotherapy of older people was selected from 14 European countries for the second version of the STOPP/START criteria, including two from the Netherlands. The translation of the second version of the STOPP/START criteria has been adapted to the situation in the Netherlands, partly by omitting drugs that are not licensed in the Netherlands.

Translated title of the contribution	Detecting inappropriate medication in older people: the revised STOPP/START criteria
Original language	Dutch
Article number	A8904
Journal	Nederlands Tijdschrift voor Geneeskunde
Volume	159
Publication status	Published - 24-Apr-2015

Access to Document

https://www.ntvg.nl/artikelen/onjuist-geneesmiddelgebruik-bij-ouderen-opsporen

Handle.net

Persistent link

Cite this

Knol, W., Verduijn, M. M., Lelie-van der Zande, A. C. A. M. R., van Marum, R. J., Brouwers, J., van der Cammen, T. J. M., Petrovic, M., & Jansen, P. A. F. (2015). Onjuist geneesmiddelgebruik bij ouderen opsporen. De herziene STOPP- en START-criteria. Nederlands Tijdschrift voor Geneeskunde, 159, Article A8904. https://www.ntvg.nl/artikelen/onjuist-geneesmiddelgebruik-bij-ouderen-opsporen

@article{68b88e0ba13d4385bea855c2a13c43ad,

title = "Onjuist geneesmiddelgebruik bij ouderen opsporen.: De herziene STOPP- en START-criteria",

abstract = "The use of potentially inappropriate medications (PIMs) by older people and potential prescribing omissions (PPOs) represent a serious problem. It increases the risk of adverse drug reactions (ADRs), however it is susceptible to influence in a substantial number of cases. Use of the STOPP/START criteria developed in Ireland to optimise pharmacotherapy of older people reduces the number of ADRs and medication errors. Licensing of new drugs, the increased number of potentially inappropriate drugs, and the availability of new literature were grounds for an update of the first version of the STOPP/START criteria which was published in 2008. In order to develop a screening tool with a broader application, a consensus panel of experts in the field of pharmacotherapy of older people was selected from 14 European countries for the second version of the STOPP/START criteria, including two from the Netherlands. The translation of the second version of the STOPP/START criteria has been adapted to the situation in the Netherlands, partly by omitting drugs that are not licensed in the Netherlands.",

author = "Wilma Knol and Verduijn, {Monique M} and {Lelie-van der Zande}, {A C A M Rian} and {van Marum}, {Rob J} and Jacobus Brouwers and {van der Cammen}, {Tischa J M} and Mirko Petrovic and Jansen, {Paul A F}",

year = "2015",

month = apr,

day = "24",

language = "Dutch",

volume = "159",

journal = "Nederlands Tijdschrift voor Geneeskunde",

issn = "0028-2162",

publisher = "NLM (Medline)",

}

TY - JOUR

T1 - Onjuist geneesmiddelgebruik bij ouderen opsporen.

T2 - De herziene STOPP- en START-criteria

AU - Knol, Wilma

AU - Verduijn, Monique M

AU - Lelie-van der Zande, A C A M Rian

AU - van Marum, Rob J

AU - Brouwers, Jacobus

AU - van der Cammen, Tischa J M

AU - Petrovic, Mirko

AU - Jansen, Paul A F

PY - 2015/4/24

Y1 - 2015/4/24

N2 - The use of potentially inappropriate medications (PIMs) by older people and potential prescribing omissions (PPOs) represent a serious problem. It increases the risk of adverse drug reactions (ADRs), however it is susceptible to influence in a substantial number of cases. Use of the STOPP/START criteria developed in Ireland to optimise pharmacotherapy of older people reduces the number of ADRs and medication errors. Licensing of new drugs, the increased number of potentially inappropriate drugs, and the availability of new literature were grounds for an update of the first version of the STOPP/START criteria which was published in 2008. In order to develop a screening tool with a broader application, a consensus panel of experts in the field of pharmacotherapy of older people was selected from 14 European countries for the second version of the STOPP/START criteria, including two from the Netherlands. The translation of the second version of the STOPP/START criteria has been adapted to the situation in the Netherlands, partly by omitting drugs that are not licensed in the Netherlands.

AB - The use of potentially inappropriate medications (PIMs) by older people and potential prescribing omissions (PPOs) represent a serious problem. It increases the risk of adverse drug reactions (ADRs), however it is susceptible to influence in a substantial number of cases. Use of the STOPP/START criteria developed in Ireland to optimise pharmacotherapy of older people reduces the number of ADRs and medication errors. Licensing of new drugs, the increased number of potentially inappropriate drugs, and the availability of new literature were grounds for an update of the first version of the STOPP/START criteria which was published in 2008. In order to develop a screening tool with a broader application, a consensus panel of experts in the field of pharmacotherapy of older people was selected from 14 European countries for the second version of the STOPP/START criteria, including two from the Netherlands. The translation of the second version of the STOPP/START criteria has been adapted to the situation in the Netherlands, partly by omitting drugs that are not licensed in the Netherlands.

M3 - Article

C2 - 25923503

SN - 0028-2162

VL - 159

JO - Nederlands Tijdschrift voor Geneeskunde

JF - Nederlands Tijdschrift voor Geneeskunde

M1 - A8904

ER -

Onjuist geneesmiddelgebruik bij ouderen opsporen. De herziene STOPP- en START-criteria

Abstract

Access to Document

Handle.net

Fingerprint

Cite this